Acute Kidney Injury (AKI) - Epidemiology Forecast - 2030

Acute Kidney Injury (AKI) - Epidemiology Forecast - 2030

  • April 2020 •
  • 100 pages •
  • Report ID: 5885419 •
  • Format: PDF
‘Acute Kidney Injury (AKI) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acute Kidney Injury (AKI) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Acute Kidney Injury (AKI) Understanding
AKI is characterized by a rapid fall in glomerular filtration rate, clinically manifest as an abrupt and sustained rise in urea and creatinine. Life threatening consequences include volume overload, hyperkalaemia, and metabolic acidosis. As per the American Kidney Foundation organization, AKI was formerly called Acute Kidney Injury. The disease leads to abrupt loss of kidney function, leading to the retention of waste products, electrolyte disturbances, and volume status changes. Acute Kidney Injury is classified into three different phases including prerenal, postrenal and intrinsic renal. Pre-renal ARI is characterized by inadequate blood circulation to the kidneys, which leaves them to clean the body properly. Post-renal is characterized by acute obstruction to urinary flow which increases intratubular pressure and decreases GFR. Intrinsic AKI is the third type, which shows direct damage to kidneys by inflammation, toxins, drugs, and infections. The risk factors associated with AKI include age, exposure to nephrotoxins, family history, race and ethnicity, gender and others.
Acute Kidney Injury (AKI) Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Incident Cases of Acute Kidney Injury, Discharge Diagnosed Cases of Acute Kidney Injury, Stage-Wise Discharged Diagnosed Cases of Acute Kidney Injury, Risk Factor Associated Acute Kidney Injury Cases and Renal Transplantation Associated Delayed Graft Function scenario of Acute Kidney Injury (AKI) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.
Acute Kidney Injury (AKI) Detailed Epidemiology Segmentation
• The total incident population of Acute Kidney Injury in the seven major markets was found to be 1,525,519 in 2017. In the United States the incident population of Acute Kidney Injury was 895,078 in 2017, which is expected to increase in the forecast period (2020–2030).
• the analyst also estimates higher Diagnosed Discharge Cases of AKI in the United States with 532,830 diagnosed discharge cases found in 2017.
• According to KIDGO staging; stage II AKI corresponds to the relatively higher diagnosed discharge population with 223,789 cases in 2017 in the United States.


Scope of the Report
• The report covers the descriptive overview of Acute Kidney Injury (AKI), explaining its causes, signs and symptoms, pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of Acute Kidney Injury (AKI).
• The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Acute Kidney Injury (AKI), Total Diagnosed and Treated Cases of Acute Kidney Injury (AKI).

Report Highlights
• Eleven Year Forecast of Acute Kidney Injury (AKI)
• Acute Kidney Injury (AKI) Epidemiology Segmentation (The segmentation consists of wider landscape covering different scenarios for developing the AKI model)
• The report covers Stage-Wise Discharge Diagnosed Cases of Acute Kidney Injury, which includes stages of AKI such as Stage I, Stage II and Stage III. Out of all the stages, Stage II showed the highest diagnosed discharge cases of AKI.
• The report also include Risk Factor Associated Acute Kidney Injury Cases, wherein several risk factors such as Coronary artery disease, Chronic kidney disease, Chronic lung disease, Sepsis, Cardiac surgery, etc are throroughly studied.
• An important segment of the report, i.e., Renal Transplantation Associated Delayed Graft Function provides scenario of Delayed Graft Function cases who undergo Renal Transplantation.
• 7MM Coverage

Key Questions Answered
• What is the disease risk, burden and unmet needs of Acute Kidney Injury (AKI)?
• What is the historical Acute Kidney Injury (AKI) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
• What would be the forecasted patient pool of Acute Kidney Injury (AKI) at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Acute Kidney Injury (AKI)?
• Out of the above-mentioned countries, which country would have the highest prevalent population of Acute Kidney Injury (AKI) during the forecast period (2020–2030)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2020–2030)?



Reasons to buy
The Acute Kidney Injury (AKI) report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM Acute Kidney Injury (AKI) market.
• Quantify patient share distribution in the 7MM for Acute Kidney Injury (AKI).
• The Acute Kidney Injury (AKI) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Acute Kidney Injury (AKI) epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2017–2030